Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M707390200 on February 22, 2008

J. Biol. Chem., Vol. 283, Issue 20, 14063-14071, May 16, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
283/20/14063    most recent
M707390200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Piper Hanley, K.
Right arrow Articles by Hanley, N. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Piper Hanley, K.
Right arrow Articles by Hanley, N. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Ectopic SOX9 Mediates Extracellular Matrix Deposition Characteristic of Organ Fibrosis*Formula

Karen Piper Hanley{ddagger}§1, Fiona Oakley, Sarah Sugden{ddagger}§, David I. Wilson{ddagger}§, Derek A. Mann, and Neil A. Hanley{ddagger}§2

From the {ddagger}Centre for Human Development, Stem Cells & Regeneration, and the §Human Genetics Division, University of Southampton, Southampton General Hospital, Southampton SO16 6YD, United Kingdom and the Liver Research Group, Institute of Cellular Medicine, University of Newcastle, Newcastle-upon-Tyne NE2 4HH, United Kingdom

Appropriate temporospatial expression of the transcription factor SOX9 is important for normal development of a wide range of organs. Here, we show that when SOX9 is expressed ectopically, target genes become expressed that are associated with disease. Histone deacetylase inhibitors in clinical trials for cancer therapy induced SOX9 expression via enhanced recruitment of nuclear factor Y (NF-Y) to CCAAT elements in the SOX9 proximal promoter. The effect of histone deacetylase inhibitors could be elicited in cells that normally lack SOX9, such as hepatocytes. In human fetal hepatocytes, this aberrant induction of SOX9 protein caused ectopic expression of COL2A1 and COMP1 that encode extracellular matrix (ECM) components normally associated with chondrogenesis. Previously, ectopic expression of this "chondrogenic" profile has been implicated in vascular calcification. More broadly, inappropriate ECM deposition is a hallmark of fibrosis. We demonstrated that induction of SOX9 expression also occurred during activation of fibrogenic cells from the adult liver when the transcription factor was responsible for expression of the major component of fibrotic ECM, type 1 collagen. These combined data identify new aspects in the regulation of SOX9 expression. They support a role for SOX9 beyond normal development as a transcriptional regulator in the pathology of fibrosis.


Received for publication, September 4, 2007 , and in revised form, February 22, 2008.

* The work described in this manuscript has been filed as patent application 0709506.0. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Fig. 1 and Tables 1-4.

1 To whom correspondence may be addressed: Human Genetics Division, Duthie Bldg., Mailpoint 808, Southampton General Hospital, Tremona Rd., Southampton SO16 6YD, UK. Tel.: 44-23-8079-5040; Fax: 44-23-8079-4264; E-mail: k.piper{at}soton.ac.uk.

2 Recipient of a UK Department of Health Clinician Scientist fellowship. Supported in part by the Juvenile Diabetes Research Foundation, the Wellcome Trust, and the Mason Medical Research Foundation. To whom correspondence may be addressed: Human Genetics Division, Duthie Bldg., Mailpoint 808, Southampton General Hospital, Tremona Rd., Southampton SO16 6YD, UK. Tel.: 44-23-8079-5040; Fax: 44-23-8079-4264; E-mail: n.a.hanley{at}soton.ac.uk.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement